Patents by Inventor Martin Krüger

Martin Krüger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080176833
    Abstract: This invention provides novel dihydropyridine derivatives of the formula I having protein tyrosine kinase inhibitory activity, to process for the manufacture thereof and to the use thereof for the treatment of c-Met-mediated diseases or c-Met-mediated conditions.
    Type: Application
    Filed: December 13, 2007
    Publication date: July 24, 2008
    Inventors: Marc Adler, Stefan Baeurle, Judi Bryant, Ming Chen, Yuo-Ling Chou, Paul Hrvatin, Seock-Kyu Khim, Monica Kochanny, Wheeseong Lee, Michael Mamounas, Janet Meurer Ogden, Gary Bruce Phillips, Victor Selchau, Christopher West, Bin Ye, Shendong Yuan, Martin Krueger
  • Publication number: 20080064696
    Abstract: The invention relates to substituted sulphoximines according to the general formula (I): in which A, E, G, X, R1, R2, R3, R4, R5, R6, R7, R8, m, p, q, are given in the claims, and salts thereof, to pharmaceutical compositions comprising said substituted sulphoximines, to methods of preparing said substituted sulphoximines as well as the use thereof for manufacturing a pharmaceutical composition for the treatment of diseases of dysregulated vascular growth or of diseases which are accompanied with dysregulated vascular growth, wherein the compounds effectively interfere with Tie2 signalling.
    Type: Application
    Filed: July 11, 2007
    Publication date: March 13, 2008
    Inventors: Ingo Hartung, Georg Kettschau, Hans Briem, Karl-Heinz Thierauch, Ulrich Luecking, Ulf Boemer, Martin Krueger
  • Patent number: 7340257
    Abstract: The proposed iterative method concurrently calculates maximum likelihood estimated values for the channel coefficients (h0, . . . , hL; ?h) and the DC offset (d; ?d) on the basis of a training sequence (TSC) in a TDMA mobile communications system. The SAGE algorithm leads to two recursion formulae, by means of which the iterative calculation of estimated values for the channel coefficients (h0, . . . , hL; ?h) and for the DC offset (d; ?d) is provided.
    Type: Grant
    Filed: July 29, 2005
    Date of Patent: March 4, 2008
    Assignee: Infineon Technologies AG
    Inventors: Ralf Heddergott, Claudiu Krakowski, Martin Krüger
  • Patent number: 7338958
    Abstract: This invention relates to pyrimidine derivatives of general formula I in which Q, R1, R2, R3, R4, R5, X, and m have the meanings that are contained in the description, as inhibitors of cyclin-dependent kinases and VEGF-receptor tyrosine kinases, their production as well as their use as medications for treatment of various diseases.
    Type: Grant
    Filed: October 18, 2004
    Date of Patent: March 4, 2008
    Assignee: Schering AG
    Inventors: Ulrich Luecking, Gerhard Siemeister, Martin Krueger, Rolf Jautelat
  • Patent number: 7333577
    Abstract: A method for equalization of a signal is provided, wherein the equalization is of a signal that is transmitted via a data channel based on the DF method. The method takes account of at least one interference channel, and includes processing of at least two trellis diagrams in each time unit, with the states of at least one of the trellis diagrams describing the data channel. A DF contribution that is used for processing of this trellis diagram includes information about at least one interference channel.
    Type: Grant
    Filed: August 17, 2004
    Date of Patent: February 19, 2008
    Assignee: Infineon Technologies AG
    Inventors: Burkhard Becker, Bertram Gunzelmann, Martin Krüger, Xiaofeng Wu
  • Patent number: 7310395
    Abstract: In a method for correlative estimation of a mobile radio channel on the basis of a training sequence (TS) which is transmitted via the mobile radio channel, a sequence of P received symbols is correlated with a subsequence of length P of the training sequence, in order to calculate a first estimated channel coefficient (?0(1)). Furthermore, the same sequence of P received symbols is correlated with at least some of the subsequences of the training sequence (TS) shifted through ±1, ±2, . . . , ±(Lt?1) symbol positions, in order to calculate a number of further estimated channel coefficients (?±1(1),?±2(1), . . . ,?±(Lt?1)(1)).
    Type: Grant
    Filed: April 28, 2004
    Date of Patent: December 18, 2007
    Assignee: Infineon Technologies AG
    Inventors: Martin Krüger, Ralf Heddergott, Claudiu Krakowski
  • Patent number: 7280617
    Abstract: In a method to compensate for a step DC disturbance (1) in a baseband signal in a homodyne radio receiver, the time profile of the step DC disturbance within a burst is determined. In order to produce a step-corrected baseband signal, the determined time profile (2) is then calculated from the digitized baseband signal.
    Type: Grant
    Filed: December 11, 2003
    Date of Patent: October 9, 2007
    Assignee: Infineon Technologies AG
    Inventors: Michael Cujé, Stefan Eibl, Stefan Herzinger, Martin Krüger, Xiaofeng Wu, Bin Yang
  • Publication number: 20070217550
    Abstract: A system having a signal processor for detection of a signal type of a signal has a processor is disclosed. One embodiment is designed to determine a first variable which is characteristic of a first spectrum element of the signal spectrum, and to determine a second variable which is characteristic of a second spectrum element of the signal spectrum, a system for determination of a ratio between the first variable and the second variable, and a detector which is designed to detect the signal type on the basis of the ratio.
    Type: Application
    Filed: February 15, 2007
    Publication date: September 20, 2007
    Applicant: INFINEON TECHNOLOGIES AG
    Inventors: Xiaofeng Wu, Martin Krueger
  • Publication number: 20070192096
    Abstract: A system and apparatus for establishing whether a received signal frame is an audio signal frame is disclosed. In one embodiment, the system includes a predetermined position in an audio signal frame containing a piece of secondary information for an audio characteristic of the audio data, with a selection device for selecting a succession of bits which is arranged at the predetermined position in the received signal frame. A decision-making device flags the received signal frame as an audio signal frame if the succession of bits represents the piece of secondary information.
    Type: Application
    Filed: February 9, 2007
    Publication date: August 16, 2007
    Applicant: INFINEON TECHNOLOGIES AG
    Inventors: Norbert Metz, Johann Steger, Thomas Hauser, Martin Krueger
  • Publication number: 20070135489
    Abstract: Novel VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridones and their use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are selected.
    Type: Application
    Filed: January 18, 2007
    Publication date: June 14, 2007
    Inventors: Andreas Huth, Martin Krueger, Ludwig Zorn, Stuart Ince, Rolf Bohlmann, Karl Thierauch, Andreas Menrad, Martin Haberey, Holger Hess-Stumpp
  • Patent number: 7202260
    Abstract: Novel VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridones and their use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are selected.
    Type: Grant
    Filed: June 14, 2004
    Date of Patent: April 10, 2007
    Assignee: Schering AG
    Inventors: Andreas Huth, Martin Krueger, Ludwig Zorn, Stuart Ince, Rolf Bohlmann, Karl Heinz Thierauch, Andreas Menrad, Martin Haberey, Holger Hess-Stumpp
  • Publication number: 20060264425
    Abstract: The invention relates to novel anthranilamide pyridinureas as VEGF receptor kinase inhibitors, their production and use as pharmaceutical agents for preventing or treating diseases that are triggered by persistent angiogenesis.
    Type: Application
    Filed: November 3, 2005
    Publication date: November 23, 2006
    Inventors: Rolf Bohlmann, Martin Haberey, Andreas Huth, Stuart Ince, Martin Krueger, Karl-Heinz Thierauch, Holger Hess-Stumpp
  • Patent number: 7122547
    Abstract: The invention relates to anthranilic acid amides and the use thereof as medicaments for the treatment of diseases that are triggered by persistent angiogenesis, in addition to intermediate products in the production of anthranilic acid amides.
    Type: Grant
    Filed: November 9, 1999
    Date of Patent: October 17, 2006
    Assignees: Schering AG, Novartis AG
    Inventors: Andreas Huth, Dieter Seidelmann, Karl-Heinz Thierauch, Guido Bold, Paul William Manley, Pascal Furet, Jeanette Marjorie Wood, Jürgen Mestan, Jose Brüggen, Stefano Ferrari, Martin Krüger, Eckhard Ottow, Andreas Menrad, Michael Schirner
  • Patent number: 7081468
    Abstract: Ortho-substituted anthranilic acid amides and use thereof as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are described.
    Type: Grant
    Filed: May 8, 2001
    Date of Patent: July 25, 2006
    Assignee: Schering AG
    Inventors: Martin Krueger, Andreas Huth, Orlin Petrov, Dieter Seidelmann, Karl-Heinz Thierauch, Martin Haberey, Andreas Menrad, Alexander Ernst
  • Publication number: 20060160861
    Abstract: The invention relates to novel nicotinamide pyridinureas as VEGF receptor kinase inhibitors, their production and use as pharmaceutical agents for preventing or treating diseases that are triggered by persistent angiogenesis.
    Type: Application
    Filed: November 1, 2005
    Publication date: July 20, 2006
    Inventors: Rolf Bohlmann, Martin Haberey, Andreas Huth, Stuart Ince, Martin Krueger, Karl-Heinz Thierauch, Holger Hess-Stumpp
  • Patent number: 7062241
    Abstract: Only a single, standard-independent clock rate is generated in a signal processor or a signal processing structure, and correspondingly only precisely one clock frequency generator is then arranged on the chip. The signal processing path includes at least one controllable, asynchronous decimator for transposing the reception signals present in a uniform time frame into a respective standard-specific time frame. This enables signals of a variety of mobile phone standards to be processed.
    Type: Grant
    Filed: March 14, 2003
    Date of Patent: June 13, 2006
    Assignee: Infineon Technologies AG
    Inventors: Martin Krüger, Dietmar Wenzel
  • Publication number: 20060116380
    Abstract: The invention relates to novel anthranilamide pyridinureas as VEGF receptor kinase inhibitors, their production and use as pharmaceutical agents for preventing or treating diseases that are triggered by persistent angiogenesis.
    Type: Application
    Filed: November 3, 2005
    Publication date: June 1, 2006
    Inventors: Rolf Bohlmann, Martin Haberey, Andreas Huth, Stuart Ince, Martin Krueger, Karl-Heinz Thierauch, Holger Hess-Stumpp, Andreas Reichel
  • Patent number: 7028243
    Abstract: In a method for error correcting a data signal that is transmitted via a channel and contains data blocks with associated error checking information, the data signal is first equalized, with calculated soft-bit information. In a subsequent step, the error checking information is evaluated with respect to the data block. If the evaluation of the error checking information shows that a single bit error is present in one message bit, the single bit error is corrected only when a condition that is dependent on the soft-bit information is satisfied.
    Type: Grant
    Filed: August 28, 2003
    Date of Patent: April 11, 2006
    Assignee: Infineon Technologies AG
    Inventors: Martin Krüger, Michael Weber, Xiaofeng Wu, Bin Yang
  • Patent number: 7012081
    Abstract: Substituted anthranilamides and use thereof as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis as well as their intermediate products for the production of anthranilamides are described.
    Type: Grant
    Filed: May 7, 2001
    Date of Patent: March 14, 2006
    Assignee: Schering AG
    Inventors: Martin Krueger, Andreas Huth, Orlin Petrov, Dieter Seidelmann, Karl-Heinz Thierauch, Martin Haberey, Andreas Menrad, Alexander Ernst
  • Patent number: 7002022
    Abstract: Described are compunds of formula (I), wherein W is O or S; X is NR8; Y is CR9R10—(CH2)n wherein R9 and R10 are independently of each other hydrogen or lower alkyl, and n is an integer of from and including 0 to and including 3; or Y is SO2; R2 is aryl; R2 is a mono- or bicyclic heteroaryl group comprising one or more ring nitrogen atoms with the exception that R2 cannot represent 2-phthalimidyl, and in case of Y=SO2 cannot represent 2,1,3-benzothiadiazol-4-yl; any of R3, R4, R5 and R6, independently of the other, is H or a substituent other than hydrogen; and R7 and R8, independently of each other, are H or lower alkyl; or a N-oxide or a pharmaceutically acceptable salt thereof for the preparation of a pharmaceutical product for the treatment of a neoplastic disease which responds to an inhibition of the VEGF receptor tyrosine kinase activity. The compounds of formula (I) can be used for the treatment e.g. of a neoplastic disease, such as a tumor disease, of retinopathy and age-related macular degeneration.
    Type: Grant
    Filed: April 21, 2004
    Date of Patent: February 21, 2006
    Assignees: Novartis AG, Schering Aktiengesellschaft
    Inventors: Karl-Heinz Altmann, Guido Bold, Pascal Furet, Paul William Manley, Jeanette Marjorie Wood, Stefano Ferrari, Francesco Hofmann, Jürgen Mestan, Andreas Huth, Martin Krüger, Dieter Seidelmann, Andreas Menrad, Martin Haberey, Karl-Heinz Thierauch